tetano
Editor, Senior Moderator
Cureus
. 2021 May 21;13(5):e15153.
doi: 10.7759/cureus.15153.
Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids
Hazem Ayesh[SUP] 1 [/SUP], Azizullah Beran[SUP] 1 [/SUP], Mohammed Mhanna[SUP] 1 [/SUP], Srini Hejeebu[SUP] 1 [/SUP]
Affiliations
Abstract
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts of <100 × 10[SUP]9[/SUP]/L with the absence of other blood count abnormalities. Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 which is manifested by a severe multisystemic disease. We present the case of a 76-year-old female who presented with ITP associated with COVID-19 and successfully managed with intravenous immunoglobulin and glucocorticoids.
Keywords: covid-19; glucocorticoid; immune thrombocytopenia; intravenous immunoglobulin; thrombocytopenia.
. 2021 May 21;13(5):e15153.
doi: 10.7759/cureus.15153.
Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids
Hazem Ayesh[SUP] 1 [/SUP], Azizullah Beran[SUP] 1 [/SUP], Mohammed Mhanna[SUP] 1 [/SUP], Srini Hejeebu[SUP] 1 [/SUP]
Affiliations
- PMID: 34178488
- PMCID: PMC8216579
- DOI: 10.7759/cureus.15153
Abstract
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts of <100 × 10[SUP]9[/SUP]/L with the absence of other blood count abnormalities. Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 which is manifested by a severe multisystemic disease. We present the case of a 76-year-old female who presented with ITP associated with COVID-19 and successfully managed with intravenous immunoglobulin and glucocorticoids.
Keywords: covid-19; glucocorticoid; immune thrombocytopenia; intravenous immunoglobulin; thrombocytopenia.